Benchmarking data showed sourcing approach did not reliably predict timeline, quality, or execution performance across 133 ...

Comparable expectations are emerging in the EU and UK through separate instruments. For organizations that already hold ...

As the life sciences industry continues to evolve, the ability to effectively manage and leverage preclinical CRO ...

In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, shares what she has ...

In today's ACT Brief, we examine why seizure reduction misses what families want from epilepsy trials, how lab coordination ...

True lab orchestration isn't about coordinating instruments, it's about connecting scientific intent, data, and decisions ...

Clinical trials have spent decades perfecting data capture, but the execution layer underneath it, including decision ...

Clinical development programs now take 2 years longer than they did a decade ago, yet many delays are predictable and preventable. Join us to explore how sponsors can accelerate critical decisions, ...

In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, describes how shifting patient engagement from protocol review to endpoint selection transforms ...

In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, explains why the full ...

Senior leaders reiterated that GCP expectations are geography-agnostic, and inadequate inspection access can render foreign ...

In today's ACT Brief, we examine why black-box AI fails in clinical trials, how participant understanding drives engagement ...